CJC-1295 DAC
Price range: €15.00 through €30.00
| Mg | 2mg, 5mg |
|---|
Product Overview
CJC-1295 DAC is a long-acting Growth Hormone Releasing Hormone analog designed to support endogenous growth hormone release through sustained GHRH receptor activation. It is commonly discussed in advanced peptide environments for its extended activity profile and prolonged GH-support potential.
The presence of DAC, also known as Drug Affinity Complex, allows CJC-1295 DAC to bind to circulating proteins and remain active for a significantly longer period compared to shorter GHRH analogs such as MOD GRF 1-29. This extended release profile makes it especially relevant for users looking for a more sustained growth hormone signaling environment.
In physique, recovery, and wellness contexts, CJC-1295 DAC is generally positioned as a long-acting GH-support peptide. Its role is not to replace exogenous growth hormone directly, but to support the body’s own growth hormone secretion pathways over a longer activity window.
Key Profile
- Best suited for: GH support, recovery strategies, wellness-oriented protocols
- Compound type: Long-acting GHRH analog
- Activity profile: Extended endogenous GH release support
- Protocol style: Sustained GH-axis support
- User level: Intermediate to experienced peptide users
Pharmacological Classification
- Class: Growth Hormone Releasing Hormone Analog
- Compound: CJC-1295 DAC
- Compound type: Synthetic peptide
- Modification: Drug Affinity Complex
- Target: GHRH receptor pathways
- Administration: Subcutaneous
- Main role: Long-acting endogenous growth hormone support
What Makes It Different
CJC-1295 DAC stands apart from shorter GHRH analogs because of its extended activity profile. While MOD GRF 1-29 is typically discussed around short pulse-based timing, CJC-1295 DAC is positioned around longer and more sustained GH-axis stimulation.
This makes it useful in contexts where the objective is prolonged growth hormone support rather than brief, tightly timed pulse amplification. It is generally seen as a more convenient but less “pulse-specific” option compared to shorter-acting GHRH compounds.
Mechanism of Action
CJC-1295 DAC binds to GHRH receptors in the anterior pituitary, encouraging endogenous growth hormone secretion. The DAC modification extends its biological activity by increasing its binding to circulating proteins.
This longer activity window may support downstream growth hormone-related pathways, including IGF-1 signaling context, recovery processes, tissue repair support, metabolic regulation, and overall wellness-oriented adaptation.
Performance Applications
- Supports sustained endogenous growth hormone signaling
- May complement recovery-focused peptide strategies
- Supports sleep, recovery, and adaptation pathways
- Often discussed in wellness and longevity-oriented protocols
- Relevant for users seeking long-acting GH-axis support
- Pairs conceptually with structured training, nutrition, and recovery management
Recovery & GH Support Profile
CJC-1295 DAC is best understood as a long-acting GH-support peptide rather than a direct anabolic steroid or stimulant. Its value lies in supporting the body’s own growth hormone release mechanisms over an extended period.
In performance-focused environments, it is usually positioned for users who already have their fundamentals controlled: progressive training, adequate protein intake, sleep consistency, recovery quality, and long-term health monitoring.
Potential Side Effects
Potential side effects may include water retention, temporary numbness, flushing, headaches, lethargy, increased hunger, injection site irritation, or changes in sleep perception depending on individual sensitivity.
Because CJC-1295 DAC has a longer activity window, users should pay attention to cumulative response, water retention, fatigue, appetite changes, and overall tolerance over time.
Important Considerations
CJC-1295 DAC should not be treated as a casual peptide or a shortcut for physique development. Its best use case is within a structured recovery, wellness, or GH-support strategy where sleep, nutrition, training, and health markers are already taken seriously.
Longer activity does not automatically mean better. Protocol planning should consider individual response, recovery status, total peptide exposure, water retention, appetite response, and whether other GH-support compounds are being used at the same time.
Stacking Context
CJC-1295 DAC is generally positioned within GH-support, recovery, wellness, and longevity-oriented peptide protocols where sustained activity is preferred.
It is often discussed alongside recovery-focused peptides, resistance training, sleep optimization, nutrition structure, and broader health-monitoring strategies depending on the user’s goals and experience level.
Storage & Handling
CJC-1295 DAC is typically supplied as a lyophilized peptide and requires proper reconstitution before use. Store according to product format and protect from heat, light, and contamination. Reconstituted peptide preparations generally require refrigerated storage and careful handling.
Protocol Profile
Best suited for structured GH-support strategies where sustained endogenous growth hormone signaling, recovery, sleep quality, wellness, and long-term adaptation are key priorities. Protocol planning should account for recovery status, water retention, appetite response, sleep quality, training load, total peptide exposure, and individual tolerance.
GoldenLabs Standard
GoldenLabs product pages are designed to provide clear compound information, realistic expectations, and structured guidance context without reducing long-acting GHRH analogs to exaggerated growth hormone claims.
